malignant glioma

Showing 1 - 25 of 124

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma, Malignant Glioma Trial in Duarte (Azeliragon, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Glioblastoma
  • Malignant Glioma
  • Duarte, California
    City of Hope Medical Center
Mar 6, 2023

Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)

Not yet recruiting
  • Diffuse Glioma
  • Malignant Glioma
  • Biospecimen Collection
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 6, 2023

Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

Recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Biopsy
  • +3 more
  • Birmingham, Alabama
  • +62 more
Feb 2, 2023

Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,

Recruiting
  • Malignant Glioma
  • High Grade Glioma
  • TTRNA-DC vaccines with GM-CSF
  • +4 more
  • Birmingham, Alabama
  • +2 more
Feb 2, 2023

Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)

Recruiting
  • Glioma
  • +4 more
  • 3T MRI scanner
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)

Recruiting
  • Glioblastoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))

Active, not recruiting
  • Malignant Glioma
  • +2 more
  • Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
  • Concurrent Optune and RT followed by Optune System alone
  • Los Angeles, California
  • +8 more
Jan 17, 2023

Malignant Glioma, Recurrent Brain Tumor Trial in Rochester (procedure, drug, other)

Active, not recruiting
  • Malignant Glioma
  • Recurrent Brain Neoplasm
  • Biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 5, 2023

Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +2 more
  • Radiation Therapy
  • +2 more
  • Birmingham, Alabama
  • +162 more
Dec 30, 2022

Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Boston (CARv3-TEAM-E T cells)

Not yet recruiting
  • Glioblastoma
  • +3 more
  • CARv3-TEAM-E T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Dec 13, 2022

Malignant Glioma, Glioblastoma Trial in Durham (Evolocumab)

Recruiting
  • Malignant Glioma
  • Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Oct 13, 2022

Malignant Glioma Trial in Rochester (Fluorine-18-L-dihydroxyphenylalanine)

Active, not recruiting
  • Malignant Glioma
  • Rochester, Minnesota
    Mayo Clinic
Oct 10, 2022

Malignant Brain Tumor, Malignant Glioma, Embryonal Tumor Trial in Paris, Villejuif (SonoCloud® (9 transducers))

Not yet recruiting
  • Malignant Brain Tumor
  • +2 more
  • SonoCloud® (9 transducers)
  • Paris, France
  • +2 more
Sep 26, 2022

Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

Active, not recruiting
  • Oligodendroglioma
  • +5 more
  • GBM6-AD and poly-ICLC before and after surgery
  • GBM6-AD and poly-ICLC after surgery only
  • San Francisco, California
    University of California
Sep 20, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +32 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +124 more
Aug 24, 2022

Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)

Recruiting
  • Glioblastoma
  • +5 more
  • Ipilimumab
  • +4 more
  • Birmingham, Alabama
  • +19 more
Aug 16, 2022

Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)

Recruiting
  • Anaplastic Ependymoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 17, 2022

Gliomas Using a Broad Next Generation Sequencing (NGS)Panel

Completed
  • Malignant Glioma
    • (no location specified)
    Aug 2, 2022

    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

    Completed
    • Malignant Glioma
    • +3 more
    • Dendritic Cell Vaccine
    • +3 more
    • Miami, Florida
      University of Miami
    Jul 19, 2022

    Malignant Glioma Trial in Rochester (procedure, drug, radiation, other)

    Active, not recruiting
    • Malignant Glioma
    • Diffusion Weighted Imaging
    • +6 more
    • Rochester, Minnesota
      Mayo Clinic
    Jul 15, 2022

    GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))

    Completed
    • GBM
    • +3 more
    • Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
    • Durham, North Carolina
      Duke University Medical Center
    Jun 28, 2022

    Malignant Glioma, Anxiety, Caregiver Burden Trial in Boston (Psychosocial Intervention Group, Usual Care Group)

    Active, not recruiting
    • Malignant Glioma
    • +3 more
    • Psychosocial Intervention Group
    • Usual Care Group
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jul 12, 2022

    Malignant Glioma, Brain Tumor, Recurrent Trial in Durham (D2C7-IT)

    Active, not recruiting
    • Malignant Glioma
    • Brain Tumor, Recurrent
    • Durham, North Carolina
      Preston Robert Tisch Brain Tumor Center at Duke
    Jul 12, 2022

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +35 more
    • Birmingham, Alabama
    • +113 more
    Jun 28, 2022